|
SLC25A33 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7502999050123E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.44629982937283E-10 |
| Normal-vs-Stage2 |
2.35349517652139E-11 |
| Normal-vs-Stage3 |
1.21640031380821E-10 |
| Normal-vs-Stage4 |
8.63550342344865E-11 |
| Stage1-vs-Stage2 |
3.040000E-02 |
| Stage1-vs-Stage3 |
6.808000E-01 |
| Stage1-vs-Stage4 |
3.321400E-01 |
| Stage2-vs-Stage3 |
1.284160E-01 |
| Stage2-vs-Stage4 |
3.378400E-01 |
| Stage3-vs-Stage4 |
6.768600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.3455003777807E-10 |
| Normal-vs-AfricanAmerican |
3.11879966297113E-10 |
| Normal-vs-Asian |
6.37399999448007E-08 |
| Caucasian-vs-AfricanAmerican |
3.292400E-01 |
| Caucasian-vs-Asian |
8.975200E-01 |
| AfricanAmerican-vs-Asian |
6.983400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.39440015090031E-10 |
| Normal-vs-Female |
2.51999976441653E-10 |
| Male-vs-Female |
2.977400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.25140009465952E-10 |
| Normal-vs-Extreme_Weight |
1.00970010130652E-10 |
| Normal-vs-Obese |
1.19919962848769E-10 |
| Normal-vs-Extreme_Obese |
8.633000E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.340400E-01 |
| Normal_Weight-vs-Obese |
8.454800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.858200E-01 |
| Extreme_Weight-vs-Obese |
4.256600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.932400E-01 |
| Obese-vs-Extreme_Obese |
4.580600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.25380039683876E-10 |
| Normal-vs-Age(41-60Yrs) |
1.00260022506404E-10 |
| Normal-vs-Age(61-80Yrs) |
1.75909953270548E-10 |
| Normal-vs-Age(81-100Yrs) |
3.39840044993878E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.969600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.207800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.284200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.544000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.703000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.887800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.30819849081854E-11 |
| Normal-VS-Type2 PRCC |
4.33900027019263E-10 |
| Normal-VS-KIRP CIMP |
7.75499997551776E-10 |
| Normal-VS-Unclassified PRCC |
1.12709952482248E-10 |
| Type1 PRCC-VS-Type2 PRCC |
5.976100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.570100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.828800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.772600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.503800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.691600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67880154222644E-11 |
| Normal-vs-N1 |
4.73160399749872E-11 |
| Normal-vs-N2 |
4.88539997345327E-09 |
| N0-vs-N1 |
4.742000E-01 |
| N0-vs-N2 |
4.627200E-01 |
| N1-vs-N2 |
1.711230E-01 |
|
|
